Marilyn Tuttleman

656 total citations
7 papers, 490 citations indexed

About

Marilyn Tuttleman is a scholar working on Rheumatology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marilyn Tuttleman has authored 7 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Surgery and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marilyn Tuttleman's work include Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Diabetes Treatment and Management (2 papers). Marilyn Tuttleman is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Diabetes Treatment and Management (2 papers). Marilyn Tuttleman collaborates with scholars based in United States, Italy and China. Marilyn Tuttleman's co-authors include Stephen P. Heyse, Sérgio Atala Dib, Pnina Vardi, William J. Riley, J. Stuart Soeldner, Noel K. Maclaren, George S. Eisenbarth, Maureen I Harris, C. Chantal Matkin and Jennifer L. Kelsey and has published in prestigious journals such as Diabetes Care, Diabetes and Osteoporosis International.

In The Last Decade

Marilyn Tuttleman

7 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn Tuttleman United States 7 231 186 166 112 101 7 490
Joel Steelman United States 8 47 0.2× 146 0.8× 77 0.5× 85 0.8× 53 0.5× 14 398
Zdenko Killinger Slovakia 16 81 0.4× 238 1.3× 93 0.6× 218 1.9× 64 0.6× 68 601
MP Cust United Kingdom 7 128 0.6× 210 1.1× 254 1.5× 389 3.5× 20 0.2× 13 799
L. Joseph Melton United States 8 140 0.6× 51 0.3× 50 0.3× 75 0.7× 59 0.6× 8 420
Bendt Brock-Jacobsen Denmark 6 91 0.4× 87 0.5× 170 1.0× 62 0.6× 83 0.8× 9 566
S. Dorgeret France 10 186 0.8× 48 0.3× 64 0.4× 88 0.8× 18 0.2× 16 436
A. Kotaniemi Finland 6 99 0.4× 46 0.2× 67 0.4× 134 1.2× 92 0.9× 9 343
T. Okano Japan 11 256 1.1× 18 0.1× 67 0.4× 275 2.5× 82 0.8× 23 580
F J Cowan United Kingdom 8 82 0.4× 63 0.3× 110 0.7× 98 0.9× 9 0.1× 11 352
Barbara Mawer United Kingdom 9 156 0.7× 53 0.3× 72 0.4× 288 2.6× 48 0.5× 10 627

Countries citing papers authored by Marilyn Tuttleman

Since Specialization
Citations

This map shows the geographic impact of Marilyn Tuttleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Tuttleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Tuttleman more than expected).

Fields of papers citing papers by Marilyn Tuttleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Tuttleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Tuttleman. The network helps show where Marilyn Tuttleman may publish in the future.

Co-authorship network of co-authors of Marilyn Tuttleman

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Tuttleman. A scholar is included among the top collaborators of Marilyn Tuttleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Tuttleman. Marilyn Tuttleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schwartz, Ann V., Jennifer L. Kelsey, Stefania Maggi, et al.. (1999). International Variation in the Incidence of Hip Fractures: Cross-National Project on Osteoporosis for the World Health Organization Program for Research on Aging. Osteoporosis International. 9(3). 242–253. 148 indexed citations
2.
Pillemer, Stanley R., Sarah Fowler, Barbara C. Tilley, et al.. (1997). Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. Arthritis & Rheumatism. 40(3). 419–425. 18 indexed citations
3.
Bluhm, Gilbert B., John T. Sharp, Barbara C. Tilley, et al.. (1997). Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.. PubMed. 24(7). 1295–302. 16 indexed citations
4.
Tuttleman, Marilyn, Stanley R. Pillemer, Barbara C. Tilley, et al.. (1997). A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.. PubMed. 24(10). 1910–5. 53 indexed citations
5.
Reveille, John D., Graciela S. Alarcón, Sarah Fowler, et al.. (1996). HLA—DRB1 genes and disease severity in rheumatoid arthritis. Arthritis & Rheumatism. 39(11). 1802–1807. 38 indexed citations
6.
Tuttleman, Marilyn, et al.. (1993). Attitudes and Behaviors of Primary Care Physicians Regarding Tight Control of Blood Glucose in IDDM Patients. Diabetes Care. 16(5). 765–772. 52 indexed citations
7.
Vardi, Pnina, Sérgio Atala Dib, Marilyn Tuttleman, et al.. (1987). Competitive Insulin Autoantibody Assay: Prospective Evaluation of Subjects at High Risk for Development of Type I Diabetes Mellitus. Diabetes. 36(11). 1286–1291. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026